MOSAIC

Hematological neoplasms
Acute myeloid leukemia
First-Line-Therapy (Metastatic Disease/Hematology)
Midostaurin + Gemtuzumab OzogAmIcin Combination in First-line Standard therapy for core-binding factor acute myeloid leukemia oder for FLT3-mutated acute myeloid leukemia.
Midostaurin + Gemtuzumab OzogAmIcin Combination in First-line Standard therapy for core-binding factor acute myeloid leukemia oder for FLT3-mutated acute myeloid leukemia.